The Bone Marrow Functionally Contributes to Liver Fibrosis

Gastroenterology

Volumn 130, Issue 6, 2006, Pages 1807-1821

  Russo, Francesco P ^a   Alison, Malcolm R ^b   Bigger, Brian W ^c   Amofah, Eunice ^a   Florou, Aikaterini ^a   Amin, Farhana ^a   Bou Gharios, George ^d   Jeffery, Rosemary ^e   Iredale, John P ^f   Forbes, Stuart J ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^d HAMMERSMITH HOSPITAL   (United Kingdom)

^e IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^f UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON TETRACHLORIDE; COLLAGEN; COLLAGEN TYPE 1; THIOACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CELL FUSION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FEMALE; IN SITU HYBRIDIZATION; IRRADIATION; LETHALITY; LIVER CELL; LIVER CIRRHOSIS; LIVER FIBROSIS; LIVER INJURY; LIVER PARENCHYMA; LIVER REGENERATION; MALE; MEDICAL ASSESSMENT; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; TRANSGENIC MOUSE; Y CHROMOSOME;

EID: 33646372957     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.01.036     Document Type: Article

References (38)

1. Jang Y.Y., Collector M.I., Baylin S.B., Diehl A.M., and Sharkis S.J. Hematopoietic stem cells convert into liver cells within days without fusion. Nat Cell Biol 6 (2004) 532-539
2. Harris R.G., Herzog E.L., Bruscia E.M., Grove J.E., Van Arnam J.S., and Krause D.S. Lack of a fusion requirement for development of bone marrow-derived epithelia. Science 305 (2004) 90-93
3. Ianus A., Holz G.G., Theise N.D., and Hussain M.A. In vivo derivation of glucose-competent pancreatic endocrine cells from bone marrow without evidence of cell fusion. J Clin Invest 111 (2003) 843-850
4. Kajstura J., Rota M., Whang B., Cascapera S., Hosoda T., Bearzi C., Nurzynska D., Kasahara H., Zias E., Bonafe M., Nadal-Ginard B., Torella D., Nascimbene A., Quaini F., Urbanek K., Leri A., and Anversa P. Bone marrow cells differentiate in cardiac cell lineages after infarction independently of cell fusion. Circ Res 96 (2005) 127-137
5. Camargo F.D., Finegold M., and Goodell M.A. Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners. J Clin Invest 113 (2004) 1266-1270
6. Wagers A.J., Sherwood R.I., Christensen J.L., and Weissman I.L. Little evidence for developmental plasticity of adult hematopoietic stem cells. Science 297 (2002) 2256-2259
7. Overturf K., Al-Dhalimy M., Ou C.N., Finegold M., and Grompe M. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepatocytes. Am J Pathol 151 (1997) 1273-1280
8. Lagasse E., Connors H., Al-Dhalimy M., Reitsma M., Dohse M., Osborne L., Wang X., Finegold M., Weissman I.L., and Grompe M. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 6 (2000) 1229-1234
9. Terai S., Sakaida I., Yamamoto N., Omori K., Watanabe T., Ohata S., Katada T., Miyamoto K., Shinoda K., Nishina H., and Okita K. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem (Tokyo) 134 (2003) 551-558
10. Alison M.R., Vig P., Russo F., Bigger B.W., Amofah E., Themis M., and Forbes S. Hepatic stem cells. from inside and outside the liver?. Cell Prolif 37 (2004) 1-21
11. Kanazawa Y., and Verma I.M. Little evidence of bone marrow-derived hepatocytes in the replacement of injured liver. Proc Natl Acad Sci U S A 100 Suppl 1 (2003) 11850-11853
12. McTaggart R.A., and Feng S. An uncomfortable silence while we all search for a better reporter gene in adult stem cell biology. Hepatology 39 (2004) 1143-1146
13. Gao Z., McAlister V.C., and Williams G.M. Repopulation of liver endothelium by bone-marrow-derived cells. Lancet 357 (2001) 932-933
14. Duffield J.S., Forbes S.J., Constandinou C.M., Clay S., Partolina M., Vuthoori S., Wu S., Lang R., and Iredale J.P. Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J Clin Invest 115 (2005) 56-65
15. Pinzani M., Rombouts K., and Colagrande S. Fibrosis in chronic liver diseases. diagnosis and management. J Hepatol 42 (2005) S22-S36
16. Friedman S.L. Liver fibrosis-from bench to bedside. J Hepatol 38 Suppl 1 (2003) S38-S53
17. Brenner D.A., Waterboer T., Choi S.K., Lindquist J.N., Stefanovic B., Burchardt E., Yamauchi M., Gillan A., and Rippe R.A. New aspects of hepatic fibrosis. J Hepatol 32 (2000) 32-38
18. Brittan M., Hunt T., Jeffery R., Poulsom R., Forbes S.J., Hodivala-Dilke K., Goldman J., Alison M.R., and Wright N.A. Bone marrow derivation of pericryptal myofibroblasts in the mouse and human small intestine and colon. Gut 50 (2002) 752-757
19. Direkze N.C., Forbes S.J., Brittan M., Hunt T., Jeffery R., Preston S.L., Poulsom R., Hodivala-Dilke K., Alison M.R., and Wright N.A. Multiple organ engraftment by bone-marrow-derived myofibroblasts and fibroblasts in bone-marrow-transplanted mice. Stem Cells 21 (2003) 514-520
20. Hashimoto N., Jin H., Liu T., Chensue S.W., and Phan S.H. Bone marrow-derived progenitor cells in pulmonary fibrosis. J Clin Invest 113 (2004) 243-252
21. Baba S., Fujii H., Hirose T., Yasuchika K., Azuma H., Hoppo T., Naito M., Machimoto T., and Ikai I. Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 40 (2004) 255-260
22. Forbes S.J., Russo F.P., Rey V., Burra P., Rugge M., Wright N.A., and Alison M.R. A significant proportion of myofibroblasts are of bone marrow origin in human liver fibrosis. Gastroenterology 126 (2004) 955-963
23. Yamamoto N., Terai S., Ohata S., Watanabe T., Omori K., Shinoda K., Miyamoto K., Katada T., Sakaida I., Nishina H., and Okita K. A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver. Biochem Biophys Res Commun 313 (2004) 1110-1118
24. am Esch J.S., Knoefel W.T., Klein M., Ghodsizad A., Fuerst G., Poll L.W., Piechaczek C., Burchardt E.R., Feifel N., Stoldt V., Stockschlader M., Stoecklein N., Tustas R.Y., Eisenberger C.F., Peiper M., Haussinger D., and Hosch S.B. Portal application of autologous CD133+ bone marrow cells to the liver. a novel concept to support hepatic regeneration. Stem Cells 23 (2005) 463-470
25. Murphy F.R., Issa R., Zhou X., Ratnarajah S., Nagase H., Arthur M.J., Benyon C., and Iredale J.P. Inhibition of apoptosis of activated hepatic stellate cells by tissue inhibitor of metalloproteinase-1 is mediated via effects on matrix metalloproteinase inhibition. implications for reversibility of liver fibrosis. J Biol Chem 277 (2002) 11069-11076
26. Bou-Gharios G., Garrett L.A., Rossert J., Niederreither K., Eberspaecher H., Smith C., Black C., and Crombrugghe B. A potent far-upstream enhancer in the mouse pro α 2(I) collagen gene regulates expression of reporter genes in transgenic mice. J Cell Biol 134 (1996) 1333-1344
27. Inagaki Y., Truter S., Bou-Gharios G., Garrett L.A., de Crombrugghe B., Nemoto T., and Greenwel P. Activation of Proα2(I) collagen promoter during hepatic fibrogenesis in transgenic mice. Biochem Biophys Res Commun 250 (1998) 606-611
28. 4-induced liver fibrosis, persistence of activated hepatic stellate cells, and diminished hepatocyte regeneration. FASEB J 17 (2003) 47-49
29. Olmsted-Davis E.A., Gugala Z., Camargo F., Gannon F.H., Jackson K., Kienstra K.A., Shine H.D., Lindsey R.W., Hirschi K.K., Goodell M.A., Brenner M.K., and Davis A.R. Primitive adult hematopoietic stem cells can function as osteoblast precursors. Proc Natl Acad Sci U S A 100 (2003) 15877-15882
30. Han W., Ye Q., and Moore M.A. A soluble form of human Δ-like-1 inhibits differentiation of hematopoietic progenitor cells. Blood 95 (2000) 1616-1625
31. Peters B.A., Diaz L.A., Polyak K., Meszler L., Romans K., Guinan E.C., Antin J.H., Myerson D., Hamilton S.R., Vogelstein B., Kinzler K.W., and Lengauer C. Contribution of bone marrow-derived endothelial cells to human tumor vasculature. Nat Med 11 (2005) 261-262
32. Willenbring H., Bailey A.S., Foster M., Akkari Y., Dorrell C., Olson S., Finegold M., Fleming W.H., and Grompe M. Myelomonocytic cells are sufficient for therapeutic cell fusion in liver. Nat Med 10 (2004) 744-748
33. Wang X., Willenbring H., Akkari Y., Torimaru Y., Foster M., Al-Dhalimy M., Lagasse E., Finegold M., Olson S., and Grompe M. Cell fusion is the principal source of bone-marrow-derived hepatocytes. Nature 422 (2003) 897-901
34. Arthur M.J., Mann D.A., and Iredale J.P. Tissue inhibitors of metalloproteinases, hepatic stellate cells and liver fibrosis. J Gastroenterol Hepatol 13 Suppl (1998) S33-S38
35. Ramadori G., and Saile B. Mesenchymal cells in the liver-one cell type or two?. Liver 22 (2002) 283-294
36. Cassiman D., Libbrecht L., Desmet V., Denef C., and Roskams T. Hepatic stellate cell/myofibroblast subpopulations in fibrotic human and rat livers. J Hepatol 36 (2002) 200-209
37. Magness S.T., Bataller R., Yang L., and Brenner D.A. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations. Hepatology 40 (2004) 1151-1159
38. Sakaida I., Terai S., Yamamoto N., Aoyama K., Ishikawa T., Nishina H., and Okita K. Transplantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology 40 (2004) 1304-1311